NEW BRUNSWICK, N.J.,
Oct. 2, 2017 /PRNewswire/
-- Johnson & Johnson (NYSE: JNJ) today announced the
completion of the divestiture of its Codman Neurosurgery business
to Integra LifeSciences Holding Corporation for an approximate
value of $1.045 billion, subject to customary adjustments.
The Codman Neurosurgery business offers a portfolio of devices
focused on hydrocephalus management, neuro intensive care and
cranial surgery, and generated net revenues of
approximately $371.5 million in 2016.
Johnson & Johnson remains dedicated to ischemic and
hemorrhagic stroke treatment through its newly launched Johnson
& Johnson Medical Devices Companies* platform, CERENOVUS**,
with a portfolio that includes aneurysm coils, vascular
reconstruction devices and other technologies used in the
endovascular treatment of cerebral aneurysms and stroke. The
CERENOVUS product portfolio has been expanded through the recent
acquisitions of Pulsar Vascular Inc., with a specialty in the
endovascular treatment of wide-neck bifurcated aneurysms, and
Neuravi Limited, offering extensive expertise and knowledge in
acute ischemic stroke with its EmboTrap®
Revascularization Platform.
About Johnson & Johnson
Caring for the world, one person at a time, inspires and unites
the people of Johnson & Johnson. We embrace research and
science – bringing innovative ideas, products and services to
advance the health and well-being of people. Our approximately
132,500 employees at more than 250 Johnson & Johnson operating
companies work with partners in health care to touch the lives of
over a billion people every day, throughout the
world.
About the Johnson & Johnson Medical Devices
Companies
The Johnson & Johnson Medical Devices Companies' purpose is
to reach more patients and restore more lives. Having advanced
patient care for more than a century, these companies represent an
unparalleled breadth of products, services, programs and research
and development capabilities in surgical technology, orthopaedics,
cardiovascular and specialty solutions with an offering directed at
delivering clinical and economic value to health care systems
worldwide.
*The Johnson & Johnson Medical Devices Companies comprise
the surgery, orthopaedics, and cardiovascular businesses within
Johnson & Johnson's Medical Devices segment.
**CERENOVUS is part of the Johnson & Johnson Medical Devices
Companies.
View original content with
multimedia:http://www.prnewswire.com/news-releases/johnson--johnson-announces-completion-of-codman-neurosurgery-divestiture-to-integra-lifesciences-holding-corporation-300529227.html
SOURCE Johnson & Johnson